- Study protocol
- Open Access
- Open Peer Review
Design of the sex hormones and physical exercise (SHAPE) study
BMC Public Healthvolume 7, Article number: 232 (2007)
Physical activity has been associated with a decreased risk for breast cancer. The biological mechanismn(s) underlying the association between physical activity and breast cancer is not clear. Most prominent hypothesis is that physical activity may protect against breast cancer through reduced lifetime exposure to endogenous hormones either direct, or indirect by preventing overweight and abdominal adiposity. In order to get more insight in the causal pathway between physical activity and breast cancer risk, we designed the Sex Hormones and Physical Exercise (SHAPE) study. Purpose of SHAPE study is to examine the effects of a 1-year moderate-to-vigorous intensity exercise programme on endogenous hormone levels associated with breast cancer among sedentary postmenopausal women and whether the amount of total body fat or abdominal fat mediates the effects.
In the SHAPE study, 189 sedentary postmenopausal women, aged 50–69 years, are randomly allocated to an intervention or a control group. The intervention consists of an 1-year moderate-to-vigorous intensity aerobic and strenght training exercise programme. Partcipants allocated to the control group are requested to retain their habitual exercise pattern. Primary study parameters measured at baseline, at four months and at 12 months are: serum concentrations of endogenous estrogens, endogenous androgens, sex hormone binding globuline and insuline. Other study parameters include: amount of total and abdominal fat, weight, BMI, body fat distribution, physical fitness, blood pressure and lifestyle factors.
This study will contribute to the body of evidence relating physical activity and breast cancer risk and will provide insight into possible mechanisms through which physical activity might be associated with reduced risk of breast cancer in postmenopausal women.
Most of the established risk factors for breast cancer, such as family history of the disease, early age at menarche, late age at menopause, late age at first childbirth or nulliparity are not, or not easily, amenable to intervention. Physical activity is a modifiable lifestyle characteristic that has been associated with breast cancer risk in various studies [1–22] and as such a potential means for the primary prevention of breast cancer. A recent review  showed strong evidence for an inverse association between physical activity and postmenopausal breast cancer, with risk reductions ranging from 20–80%. For premenopausal breast cancer, however, the evidence was much weaker. A recently published large cohort study, EPIC, provides additional evidence for a protective effect of physical activity on breast cancer risk . The causal pathway between physical activity and (postmenopausal) breast cancer risk, however, is not clear. Several biological mechanisms that mediate the relation between physical activity and breast cancer are suggested. The most prominent hypothesis is that physical activity affects the hormonal milieu, including sex steroid hormones and metabolic profiles [25–28]. The evidence that estrogens contribute to breast cancer risk is strong and widely accepted. Women with relatively high levels of estrogens have increased risk of developing breast cancer [29–32].
Furthermore, both an early menarche and a late menopause increase risk, probably by increasing lifetime exposure to ovarian hormones [33, 34]. Several cross-sectional studies have shown that an elevated level of physical activity is associated with 15–25% lower serum concentrations of estradiol, estrone and androgens in postmenopausal women, even after adjustment for body mass index [35–37]. In addition, a positive energy balance has been associated with (a) increased levels of active estrogens, (b) increased levels of unbound estradiol and (c) increased levels of progesterone . This association can be explained either directly but also indirectly through accumulation of adipose tissue [39, 40]. Compared with normal-weight postmenopausal women, obese postmenopausal women have higher blood concentration of both estrone and estradiol and lower concentration of sex hormone binding globulin. In postmenopausal women, increased levels of estrogens due to peripheral conversion (mainly in fat cells) from androgens result from increased body fat, particularly intra-abdominal fat mass. Regular exercise represents an approach to regulate energy balance and to prevent the accumulation of adipose reserves and consequently influence the production of estrogens. Another possible mediator in the relation between physical activity and breast cancer risk may be insulin (resistance). Several studies have shown inverse associations between physical activity and markers for insulin sensitivity independent of body size [41–45].
So far, one study has reported on the effects of an exercise intervention on sex steroid concentration among postmenopausal women. This study observed that a 12-month moderate-intensity exercise intervention in sedentary, overweight women resulted in small but significant decreases in serum estrogens and androgens. These results were restricted to women who lost a certain amount of body fat.
In order to get more insight in the causal pathway between physical activity and breast cancer risk, we designed the Sex Hormones and Physical Exercise (SHAPE) study. This study examines the effect of an exercise intervention on sex steroid hormones and insulin in sedentary postmenopausal women and investigates if the amount of total body fat or abdominal fat mediates the effect. If increase in physical activity has a beneficial effect on the sex hormone and metabolic profile of postmenopausal women, it will offer opportunities for breast cancer prevention programs. This paper presents the design and evaluation plan of the SHAPE study.
The SHAPE study examines the effects of a 1-year moderate intensity exercise programme on endogenous hormone levels (sex steroid hormones, insulin) associated with breast cancer among sedentary postmenopausal women. The study is designed as a single blind, randomised, controlled trial with two study arms.
We chose to include only postmenopausal women because (a) there is more evidence for an inverse association between physical activity and breast cancer risk in postmenopausal women (b) the incidence of breast cancer is greatest in postmenopausal years (c) the major conversion locus of androgens into estrogens in postmenopausal women is fat tissue – a reduction in fat mass through exercise may be more likely to affect the relative concentrations of estrogens on postmenopausal women than in premenopausal women (d) there are no problems associated with measurements of hormones with timing of the menstrual cycle.
The SHAPE study includes 189 healthy postmenopausal women aged 50 tot 69 year, who are sedentary and not currently using postmenopausal hormone replacement therapy. Postmenopausal status is defined as not having menstrual periods for at least 12 months. Being sedentary is defined as less than 2 hours per week of moderate sport activity (e.g., tennis, swimming, running, aerobics, fitness, and volleyball) and not adherent to the international physical activity recommendation. The international physical activity recommendation states that every adult should accumulate 30 minutes or more of at least moderately intense physical activity for at least five days per week [46, 47]. The exclusion criteria (see Table 1) are based on factors that might interfere with measurement of endogenous hormones or with the success of the intervention, or that might affect the safety of the participant. We exclude women with a BMI below 22, because these women may have estrogen levels below the detectable levels of a laboratory. The study protocol is approved by the Medical Ethics Committee of University Medical Centre Utrecht before the start of data collection.
Participants are recruited through a random selection out of the female inhabitants aging 50–69 years of the following middle sized municipalities in the centre of The Netherlands: Utrecht, Zeist, Bilthoven, Houten, Soest en IJsselstein. Potential candidates receive an invitation letter explaining the goal of the study and a short eligibility questionnaire. Next, the potential candidates are contacted by phone to explain further details and the inclusion criteria list is completed to screen eligibility. Additionally, interested and eligible women receive written study information and are asked to complete and sign an informed consent form. With the women who return their informed consent form an appointment for the baseline visit at our research unit is made. See Figure 1 for the flow chart of the inclusion of the participants.
Eligible women are randomised into an intervention group or a control group. Randomisation is blocked on two categories of waist circumference: < 92 cm and ≥ 92 cm (cut-off level is based on the median value reported in similar women ).
Women in the intervention group participate in a combined endurance and strength training programme over a period of 12 months. The programme is organised in a way to optimise fat loss. The goal of the intervention programme is to have participants exercise at least 3 times per week (i.e. twice in a supervised group session and once individual) and to reach a training stimulus in each person. In general, implementation of the exercise goals is done slowly, to reduce chance of injury and to increase participants' adherence and sense of accomplishments.
Twice a week the participants of the intervention group meet for an exercise session of one hour. Each group includes about 15–20 women. A qualified sports instructor facilitates the standardised group sessions according to a protocol. Group exercise takes place in six fitness centres located in the subjects' home town. Classes start with a 10-minute warming up: e.g. exercise to music routines and walking. Then the training is continued with moderate-to-vigorous level of aerobic exercise on 60 – 85% of the age-predicted maximum heart rate. The maximum heart rate is established as 220 minus the person's age in years. The participants receive heart rate monitors to control their training intensity. The training session ends with 25 minutes strength exercises and 5 minutes cooling down. The sport instructor registers the attendance of the subjects. Since it is important that the group exercise sessions are conducted uniformly in all centres, all instructors who participate in the SHAPE study are instructed extensively. In addition, the study coordinator (EM) performs several monitor visits per exercise group to control adherence to the protocol.
Previous experience showed that group exercises are preferred by Dutch women of this age and are better adhered to in the short and long term . However, for budgetary and practical reasons also an individual exercise session is included.
Once a week the participants are asked to perform an individual home-based exercise session. They receive instructions during the group sessions. The home-based exercise programme consists of 30 minutes brisk walking or cycling with an intensity of moderate-to-vigorous intensity (60–80% of maximal heart rate). Afterwards, the women record the type and duration of their activity in an exercise log, together with the mean heart rate during the training and the BORG-score (6–20) for exertion .
Participants in the control group are requested to retain their habitual exercise pattern. They also receive newsletters. Although some control subjects may decide to increase their level of physical activity, we believe that it is unlikely that they will sustain in a similar level as the intervention group. Level of physical activity is measured frequently to monitor changes in physical activity (PASE questionnaire) during the course of the intervention.
Outcomes and measurements
The study participants visit the research unit of the Julius Center at baseline, after 4 months and at the end of the study (See table 2). To evaluate the effects of the exercise intervention and potential confounding factors, data are collected in several ways, i.e., by blood samples, physical examination and questionnaires. Socio-demographic information, reproductive factors, smoking information, past physical activity and medical history is collected by a self-constructed questionnaire at baseline only. Besides blood sampling, anthropometric measurements including dual-energy x-ray absorptiometry (DEXA) and ultrasound of the abdomen, blood pressure measurements and a submaximal exercise test is performed each visit. Also, medication use is assessed each visit. Furthermore, habitual physical activity and diet are assessed at baseline and at the end of the study. Level of physical activity is assessed every four months to investigate changes during the intervention period in both groups either in person or by phone.
Blood samples (30 ml per visit) are drawn between 9.00 and 11.00 AM after an overnight fast in order to determine serum concentrations of estradiol (total, free), estrone, estrone sulfate testosterone, androstenedione, insuline, glucose and sex hormone binding globulin. Blood samples are stored at -70°C. All samples from an individual subject are analysed in the same batch since the batch-to-batch variation can be higher than any woman's likely change in hormones over the year . Serum estrogens, androgens, insulin and sex hormone binding globuline (SHBG) are determined by use of commercially available double-antibody radioimmunoassay kits.
The laboratory "Stichting Huisartsenlaboratorium Oost" in Velp  performs all assays.
Body weight and height (to the nearest 0.5 kg and 0.5 cm respectively) are measured while the subjects wear light clothes and no shoes using an analogue balance (SECA) and wall-mounted tape measure.
Body fat distribution is measured by the waist- and hip circumference. Waist circumference (to the nearest 0.1 cm) was measured standing at the midway between lower ribs and iliac crest. Hip circumference (to the nearest 0.1 cm) was measured standing over the buttocks. All measurements were taken in duplicate and averaged. Total body fat and body fat percentage are determined by using a whole-body DEXA scan (Lunar, Prodigy™). A whole body scan analyses body composition according to a three-compartment model: fat mass, lean tissue, and bone mineral content. The standard soft tissue analysis is performed using software supplied by the manufacturer. Total body fat is estimated for each subject in kilograms.
Intra-abdominal fat is measured by abdominal ultrasound assessment (Acuson Aspen, Siemens). The ultrasound measure comprises the distance between the peritoneum and the lumbar spine at three predefined places. All measurements are performed longitudinally from one line over the abdomen halfway between the lower rib and iliac crest.
Blood pressure is measured with an automatically tonometer (OMRON M4) after participants have been sitting quietly for at least five minutes.
Fitness is measured by the maximal oxygen uptake (VO2 max). VO2 max is determined by a submaximal cycle test: the Fit Test programme on a Life Fitness cycle ergometer. The theory of the test is based on the Ästrand Rhyming Protocol , in which, a submaximal heart rate at a known workload is used to predict maximal aerobic capacity. The participants wear light clothing and a heart rate monitor. Prior to each test, the seat height of the cycle ergometer is adjusted for near full extension of the subject's leg while pedalling and is kept the same during the whole study. Before the start of the test, weight, age and gender is entered in the programme. Additionally, a resistance level that suits the subject is chosen. Guidelines for the resistance level have been specified in the manual of the manufacturer. During the test, the subject pedals for 5 minutes using a relatively consistent cadence. The subject should exercise with an intensity of 60 – 85% of the age-predicted maximum heart rate (220 – age). Towards the end of the 5 minutes, the programme measures the heart rate via telemetry. Once a steady heart rate reading is acquired, the programme calculates a VO2 max estimate based on the subject's weight, age, gender, selected resistance, and steady-state heart rate. After the test, the subject pedals without resistance for 2 minutes to cool down.
To assess reproducibility of the Fit Test, we tested 25 volunteers twice with an average period of 2.0 ± 1.5 days between the tests. Group means and standard deviations of the first and second VO2max measurement were almost identical: 38.9 ± 6.5 ml/kg/min versus 38.8 ± 6.5 ml/kg/min, respectively. The test-retest reliability (i.e. Pearson's correlation coefficient) was 0.993 (P < 0.001). Other reliability indexes (i.e. Intraclass Correlation Coefficient, Standard Error of Measurement and Smallest Detectable Difference) were respectively 0.993, 0.532 ml/kg/min and 1.475 ml/kg/min. This reproducibility study showed that the Fit Test is a reproducible measure of submaximal work capacity.
A self-constructed questionnaire (general questionnaire) is used to assess level of physical activity, diet, socio-demographic variables, smoking history, medical history and reproductive factors.
Habitual-, occupational- and physical activity in the past
The general physical activity questionnaire includes the Voorrips questionnaire measuring habitual activity in elderly subjects  and questions concerning occupational physical activity and activity in the past. The Voorrips questionnaire includes household activities, sporting activities and other physically active leisure activities. Altogether it leads to an overall activity score. In the questionnaire, the respondents are asked to report habitual physical activities of the last year. Items on household activities are questions with four to five possible ratings from active to inactive. Sports and other activities are asked as type of activity, hours per week spent on it, and period of the year in which the activity is normally performed. All activities are classified according to work posture and movements. An intensity code, originally based on Bink et al , is used to classify each activity.
Recent physical activity
The PASE (Physical Activity Scale for the Elderly) questionnaire  measures occupational, household and leisure- related activities over a 1-week period. This questionnaire includes 12 categories of physical activity and records the frequency of participation in these activities over the preceeding 7 days. Scoring procedures were derived from motion sensor counts, physical activity diaries and a global activity self-assessment . The PASE generates a single composite score of physical activity that ranges from 0 – 400. We modified the PASE slightly by adding additional answer categories for the duration of the activities. We divided the category "less than 1 hour" into "less than 30 minutes", "30–45 minutes" and "45 minutes – 1 hour" in order to compare the activity level of the participants with the international recommendations for prevention of obesity. The calculation of the PASE score is modified accordingly.
Daily caloric intake, percent daily calories from fat, percent daily calories from carbohydrates and proteins is determined by a food frequency questionnaire [57, 58]. The questionnaire consists of 74 items. The questionnaire is completed by the participants at home and subsequently checked by a dietician at the research unit.
Medication use is asked each visit and registered by use of an internet database. This database is based on the current available medications and uses ATC codes.
All randomised subjects will be analysed according to the intent-to-treat principle. The intention-to-treat principle will assess the intervention effect based on assigned treatment at the time of randomisation regardless of adherence. Demographics and baseline characteristics will be reported descriptively. We will assess whether life style factors that are potentially related to hormone levels might have changed differentially between exercisers and controls, including alcohol use and caloric intake. Differences between the treatment groups in primary and secondary efficacy parameters will be analysed by repeated measurement analyses in SAS and 95% confidence intervals will be calculated. We will also assess effect modification by change in intra-abdominal (and total body fat) and, among exercisers only, by adherence levels.
In this paper, we present the rationale and design of the SHAPE trial which aims to get more insight in the biological mechanism underlying the observed effect between physical activity and breast cancer risk.
The success of the study will depend to a large extent on adherence to the exercise protocol. Factors that enhance adherence to exercise programmes in The Netherlands are group exercise (in stead of individual), a varied programme and a regular instructor . We incorporated all three factors in the SHAPE study as much as possible. First, group exercise comprises the most important part of the total exercise programme. Second, the aerobic component of the exercise programme can be varied to a large extent by the sport instructors. The strength exercises, however, are highly standardised and repetitive which might be less challenging for the women. We choose for this type of strength training for two important reasons: 1) to decrease the risk of injury and 2) since this type of strength training is most optimal to increase muscle mass. Third, we opt for regular instructors for all training groups during the follow-up period, however, in practice there may be some changes during the year. Additional procedures that we use to enhance adherence are: personal feedback, use of exercise logs and newsletters.
It is also of utmost importance that the control group is compliant with the study protocol, e.g., retaining their habitual lifestyle pattern. Women who are randomised to the control group might be disappointed about the assignment and may take up exercise or change their diet. We monitor the level of physical activity of all participants with questionnaires in order to get insight in the actual amount of physical activity and potential cross-over between both treatment arms. Changes in diet are monitored by a food frequency questionnaire.
Six fitness centres and fourteen instructors participate in the SHAPE study. Although the exercise protocol is standardised as much as possible, the attitude and experience of the instructor might influence the actual performance of the participants. In the analysis, we will explore whether outcomes of participants within the same sporting centre are correlated (intracluster correlation). If there is evidence for intracluster correlation, we will account for this in the analysis.
Because of the stringent in and exclusion criteria, the participants of the SHAPE study comprise a selected group of postmenopausal women. This type of preselection will not affect the validity of the study (no selection bias) because randomisation is aimed to ensure comparability of intervention and control group but it may limit the generalisability. For example, since we exclude lean women and women not using hormone replacement therapy, the results might not be generalised to these groups of women.
So far, one study (PATH study) has been published on the effects of exercise interventions on sex steroid concentration in women . The PATH study observed that a 12-month moderate-intensity exercise intervention in sedentary, overweight, postmenopausal women resulted in significant decreases in serum estrogens and androgens. These results were restricted to women who lost body fat, e.g., among women who lost > 2% of body fat, serum estradiol and testosterone concentrations fell by 13.7% and 10.1 % between baseline and 12 months in exercisers compared with a increase of 4.7% and a decrease of 1.6% in controls, respectively [61, 62]. Two other controlled physical activity intervention studies in postmenopausal women are under way. These are the ALPHA trial (Alberta Physical Activity and Breast Cancer Prevention Trial)  and The NEW Trial (Nutrition and Exercise for Women) . The Alpha trial examines the effect of a 12-month aerobic exercise intervention compared with a usual sedentary lifestyle on several biomarkers of breast cancer risk in 330 sedentary postmenopausal women. The NEW trial is a 4-arm trial examining the effects of diet and exercise induced weight loss on biomarkers of breast cancer risk in 503 sedentary postmenopausal women randomly assigned to dietary weight loss alone, exercise alone, dietary weight loss plus exercise, or usual lifestyle control. Together, these results will shed important light on biological mechanisms by which physical activity influences breast cancer risk. These studies may also give information about the type of exercise needed for breast cancer risk reduction.
In summary, this paper shows the rationale and design of the SHAPE study. The SHAPE study aims to unravel the mechanisms underlying the association physical activity and breast cancer risk. Furthermore, this study evaluates the feasibility of delivering an exercise programme for postmenopausal women.
Body Mass Index
Dual-Energy X-ray Absorptiometry
Sex Hormone Binding Globulin
Maximum Oxygen Uptake
Anatomical Therapeutic Chemical Classification System
Cerhan JR: Physical activity, physical function, and the risk of breast cancer in a prospective study among elderly women. J Gerontol A Biol Sci Med Sci. 1998, 53: M251-M256.
Sesso HD, Paffenbarger RS, Lee IM: Physical activity and breast cancer risk in the College Alumni Health Study (United States). Cancer Causes Control. 1998, 9: 433-439. 10.1023/A:1008827903302.
Thune I, Brenn T, Lund E, Gaard M: Physical activity and the risk of breast cancer. N Engl J Med. 1997, 336: 1269-1275. 10.1056/NEJM199705013361801.
Wyshak G, Frisch RE: Breast cancer among former college athletes compared to non-athletes: a 15-year follow-up. Br J Cancer. 2000, 82: 726-730. 10.1054/bjoc.1999.0987.
Wyrwich KW, Wolinsky FD: Physical activity, disability, and the risk of hospitalization for breast cancer among older women. J Gerontol A Biol Sci Med Sci. 2000, 55: M418-M421.
Patel AV, Callel EE, Bernstein L, Wu AH, Thun MJ: Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control. 2003, 14: 519-529. 10.1023/A:1024895613663.
McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, Woods N, Ockene J: Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA. 2003, 290: 1331-1336. 10.1001/jama.290.10.1331.
Breslow RA, Ballard-Barbash R, Munoz K, Graubard BI: Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Epidemiol Biomarkers Prev. 2001, 10: 805-808.
Yang D, Bernstein L, Wu AH: Physical activity and breast cancer risk among Asian-American women in Los Angeles: a case-control study. Cancer. 2003, 97: 2565-2575. 10.1002/cncr.11364.
Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K: Physical activity and the risk of breast cancer: a case-control study of Japanese women. J Epidemiol. 1998, 8: 116-122.
Moradi T, Nyren O, Zack M, Magnusson C, Persson I, Adami HO: Breast cancer risk and lifetime leisure-time and occupational physical activity (Sweden). Cancer Causes Control. 2000, 11: 523-531. 10.1023/A:1008900512471.
Matthews CE, Shu XO, Jin F, Dai Q, Hebert JR, Ruan ZX, Gao YT, Zheng W: Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer. 2001, 84: 994-1001. 10.1054/bjoc.2000.1671.
Marcus PM, Newman B, Moorman PG, Millikan RC, Baird DD, Qaqish B, Sternfeld B: Physical activity at age 12 and adult breast cancer risk (United States). Cancer Causes Control. 1999, 10: 293-302. 10.1023/A:1008971417282.
Levi F, Pasche C, Lucchini F, La Vecchia C: Occupational and leisure time physical activity and the risk of breast cancer. Eur J Cancer. 1999, 35: 775-778. 10.1016/S0959-8049(99)00051-9.
Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni JF: Risk factors for male breast cancer (United States). Cancer Causes Control. 1998, 9: 269-275. 10.1023/A:1008869003012.
Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM: Physical activity and breast cancer risk in hispanic and non-hispanic white women. Am J Epidemiol. 2001, 154: 442-450. 10.1093/aje/154.5.442.
Friedenreich CM, Rohan TE: Physical activity and risk of breast cancer. Eur J Cancer Prev. 1995, 4: 145-151. 10.1097/00008469-199504000-00004.
Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A: Risk factors for male breast cancer--a case-control study from Scandinavia. Acta Oncol. 2001, 40: 467-471.
D'Avanzo B, Nanni O, La Vecchia C, Franceschi S, Negri E, Giacosa A, Conti E, Montella M, Talamini R, Decarli A: Physical activity and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996, 5: 155-160.
Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L: Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer. 2003, 106: 96-102. 10.1002/ijc.11186.
Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK: Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 1994, 86: 1403-1408. 10.1093/jnci/86.18.1403.
Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR: Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc. 2001, 93: 267-275.
Monninkhof EM, Elias SG, Vlems FA, van T, Schuit AJ, Voskuil DW, van Leeuwen FE: Physical activity and breast cancer: a systematic review. Epidemiology. 2007, 18: 137-157. 10.1097/01.ede.0000251167.75581.98.
Lahmann PH, Friedenreich C, Schuit AJ, Salvini S, Allen NE, Key TJ, Khaw KT, Bingham S, Peeters PH, Monninkhof E, Bueno-de-Mesquita HB, Wirfalt E, Manjer J, Gonzales CA, Ardanaz E, Amiano P, Quiros JR, Navarro C, Martinez C, Berrino F, Palli D, Tumino R, Panico S, Vineis P, Trichopoulou A, Bamia C, Trichopoulos D, Boeing H, Schulz M, Linseisen J, Chang-Claude J, Chapelon FC, Fournier A, Boutron-Ruault MC, Tjonneland A, Fons JN, Overvad K, Kaaks R, Riboli E: Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007, 16: 36-42. 10.1158/1055-9965.EPI-06-0582.
Bernstein L, Ross RK, Lobo RA, Hanisch R, Krailo MD, Henderson BE: The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer. 1987, 55: 681-685.
IARC Handbooks of Cancer Prevention. Weight control and physical activity. Edited by: Vainio H and Bianchini F. 2002, Lyon, IARC Press
Kelley DE, Goodpaster BH: Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc. 1999, 31: S619-S623. 10.1097/00005768-199911001-00021.
van Baak MA, Borghouts LB: Relationships with physical activity. Nutr Rev. 2000, 58: S16-S18.
Colditz GA: Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998, 90: 814-823. 10.1093/jnci/90.11.814.
Thomas HV, Reeves GK, Key TJ: Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control. 1997, 8: 922-928. 10.1023/A:1018476631561.
Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002, 94: 606-616.
Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003, 95: 1218-1226.
Colditz GA: Epidemiology of breast cancer. Findings from the nurses' health study. Cancer. 1993, 71: 1480-1489.
Feigelson HS, Henderson BE: Estrogens and breast cancer. Carcinogenesis. 1996, 17: 2279-2284. 10.1093/carcin/17.11.2279.
Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG: The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989, 129: 1120-1131.
Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD: Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol. 1991, 20: 151-156. 10.1093/ije/20.1.151.
Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ: Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab. 1988, 66: 927-933.
Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993, 15: 17-35.
Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC: Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997, 278: 1407-1411. 10.1001/jama.278.17.1407.
Vainio H, Kaaks R, Bianchini F: Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2002, 11 Suppl 2: S94-100.
Regensteiner JG, Mayer EJ, Shetterly SM, Eckel RH, Haskell WL, Marshall JA, Baxter J, Hamman RF: Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care. 1991, 14: 1066-1074. 10.2337/diacare.14.11.1066.
Feskens EJ, Loeber JG, Kromhout D: Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am J Epidemiol. 1994, 140: 350-360.
Borghouts LB, Keizer HA: Exercise and insulin sensitivity: a review. Int J Sports Med. 2000, 21: 1-12. 10.1055/s-2000-8847.
Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW: Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care. 2003, 26: 557-562. 10.2337/diacare.26.3.557.
Chlebowski RT, Pettinger M, Stefanick ML, Howard BV, Mossavar-Rahmani Y, McTiernan A: Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications. J Clin Oncol. 2004, 22: 4507-4513. 10.1200/JCO.2004.04.119.
Kemper HGC, Ooijendijk WTM, Stiggelbout M: Concensus over de Nederlandse Norm voor Gezond Bewegen. TSG: Tijdschrift voor Gezondheidswetenschappen. 2000, 78: 180-183.
Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, .: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995, 273: 402-407. 10.1001/jama.273.5.402.
Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH: Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2001, 17: 1047-1053. 10.1023/A:1020009325797.
Schuit AJ: Regular Physical activity in old age. Effect on coronary heart disease risk factors and well-being. 1997
Borg G: Ratings of perceived exertion and heart rates during short-term cycle exercise and their use in a new cycling strength test. Int J Sports Med. 1982, 3: 153-158.
Tworoger SS, Yasui Y, Chang L, Stanczyk FZ, McTiernan A: Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1257-1260. 10.1158/1055-9965.EPI-03-0026.
Stichting Huisartsenlaboratorium Oost. 2007, [http://www.labsho.nl]
ASTRAND PO, RYHMING I: A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954, 7: 218-221.
Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, van Staveren WA: A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991, 23: 974-979.
Bink B, Bonjer FH, van der Sluys H: Physical activity in health and disease. Edited by: Edang K and Lange Andersen K. 2004, Oslo, Oslo University, 207-214. Assessment of the energy expenditure by indirect time and motion study, Proceedings of the Bertostolen Symposium
Schuit AJ, Schouten EG, Westerterp KR, Saris WH: Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol. 1997, 50: 541-546. 10.1016/S0895-4356(97)00010-3.
Feunekes GI, van Staveren WA, De Vries JH, Burema J, Hautvast JG: Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr. 1993, 58: 489-496.
Feunekes IJ, van Staveren WA, Graveland F, De Vos J, Burema J: Reproducibility of a semiquantitative food frequency questionnaire to assess the intake of fats and cholesterol in The Netherlands. Int J Food Sci Nutr. 1995, 46: 117-123.
Health NIP: Time for healthy living: health promotion for specific target groups. Edited by: Jansen J SAJLF. 2002, Houten, Bohn Stafleu Van Loghum
McTiernan A, Ulrich CM, Yancey D, Slate S, Nakamura H, Oestreicher N, Bowen D, Yasui Y, Potter J, Schwartz R: The Physical Activity for Total Health (PATH) Study: rationale and design. Med Sci Sports Exerc. 1999, 31: 1307-1312. 10.1097/00005768-199909000-00012.
McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS: Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1099-1105.
McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, Stanczyk FZ, Potter JD, Schwartz RS: Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 2004, 64: 2923-2928. 10.1158/0008-5472.CAN-03-3393.
Alpha trial. 2007, [http://www.cancerboard.ab.ca/alphatrial/who.html]
NEW study. 2007, [http://www.fhcrc.org/science/phs/NEW/]
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/7/232/prepub
First, we would like to thank all participating women. Furthermore, we gratefully acknowledge Manon de Leeuw, Anneloes van Diemen, Claire Nollen, Karin Menninga, Lizeth Vendrig, Lara Heuveling, Jose Drijvers, Joke Metselaars and Fien Stern for their contribution to the inclusion and follow-up of the SHAPE participants. We would like to thank the following sport centres for their participation in the SHAPE study: Healthclub Fysio Physics, IJsselstein; Better Bodies Health Club, Bilthoven and Zeist; Maxfit Europe, Houten; Body Business, Utrecht; Physiotherapy Center Basten-Kries, Soest. Finally, we would like to thank all sport instructors for their dedication to the SHAPE study.
The trial is sponsored by the Dutch Cancer Society (Project number: UU 2003-2793).
The author(s) declare that they have no competing interests.
EMM, PHMP and AJS designed the study, participated in the coordination of the study and writing of the article. All authors provided comments on the draft and have read the paper.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.